Clinical Trials and the African Person

Ike V. Iyioke, Ph.D. (2015) Michigan State University, has backgrounds in philosophy, international relations, journalism, and teaching. He has taught healthcare ethics, business ethics, and African philosophy. A MacArthur Foundation/SSRC Fellow, his career has included print journalism and university administration.

Preface

Acknowledgements

List of Figures

List of Abbreviations/Terms



Introduction



Part 1: Clinical Trials

1 Who is Responsible for Human Subjects (When Experiments Travel)?

 1.1 Introduction

 1.2 Experimentation with Human Subjects: A Selective Rehash

  1.2.1 Burroughs Wellcome (Now GlaxoSmithKline) Experiments

  1.2.2 Tuskegee Syphilis Study (1932–1972)

  1.2.3 Nuremberg Experiments

  1.2.4 Radiation Experiments

  1.2.5 Mustard gas Experiments

  1.2.6 Thalidomide

  1.2.7 Henry Beecher Report

  1.2.8 Jewish Chronic Disease Hospital and Willowbrook Tests

 1.3 Emergence of Research Ethics Codes

 1.4 Outsourcing of Clinical Trials

 1.5 Trovan Test Case

 1.6 Concluding Thoughts

2 Transgenic Mosquitoes Project as Model

 2.1 Introduction

 2.2 Some Preliminaries

 2.3 The GMM Model

 2.4 GMM Model and Biodiversity

 2.5 Environmental Ethics and Bioethics

 2.6 Concluding Thoughts



Part 2: Responsibility

3 Being Responsible

 3.1 Introduction

 3.2 Understanding Responsibility

 3.3 Responsibility as a Virtue

 3.4 Corporate Responsibility

 3.5 Concluding Thoughts



Part 3: Personhood

4 Re-Conceiving Responsibility: A Role For Personhood in African Thought

 4.1 Introduction

 4.2 The ‘African Man’

 4.3 African vs. Euro-American Personhood

 4.4 African Personhood and Bioethics

 4.5 Summary

 4.6 The Die is Cast

 4.7 Concluding Thoughts

 4.8 Study Limitations/Directions for Future Studies



Bibiliography

Index